Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with gastric cancer.

From: PSMC2 promotes the progression of gastric cancer via induction of RPS15A/mTOR pathway

Features

No. of patients

PSMC2 expression

P value

Low

High

All patients

93

57

36

 

Age (years)

   

0.016*

≤65

47

35

12

 

>65

44

22

22

 

Gender

   

0.244

Male

61

40

21

 

Female

32

17

15

 

Grade

   

0.715

2

13

7

6

 

3

70

44

26

 

4

10

6

4

 

Tumor Infiltrate

   

0.003**

T1

7

7

0

 

T2

7

5

2

 

T3

59

37

22

 

T4

19

7

12

 

Lymphatic metastasis (N)

   

0.088

N0

24

18

6

 

N1

13

8

5

 

N2

25

14

11

 

N3

29

15

14

 

Tumor metastasis

   

0.512

No

84

52

32

 

Yes

8

4

4

 

Stage

   

0.011*

1

9

7

2

 

2

28

22

6

 

3

47

22

25

 

4

7

4

3

 

Tumor size

   

0.156

<6 cm

45

31

14

 

≥6 cm

46

25

21

 

Lymph node positive

   

0.077

≤4

46

32

14

 

>4

43

22

21

 

Expression of Ki67

   

0.015*

Low

51

37

14

 

High

42

20

22